Here’s Why CRISPR Therapeutics AG Gained as Much as 14% Today – Motley Fool
GlobeNewswire (press release) |
Here's Why CRISPR Therapeutics AG Gained as Much as 14% Today
Motley Fool Shares of gene-editing pioneer CRISPR Therapeutics AG (NASDAQ:CRSP) dropped 14% today after the company announced full-year 2017 earnings and provided shareholders with a business update for what to expect in the year ahead. In the fourth quarter of … CRISPR Therapeutics Provides Business Update and Reports Fourth Quarter and Full Year 2017 Financial Results CRISPR Therapeutics AG (NASDAQ:CRSP): Financial Strength Analysis Should You Consider CRISPR Therapeutics AG (CRSP) Based on Their Fundamentals? |
